Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
Olukoya AO, Stires H, Bahnassy S, Persaud S, Guerra Y, Ranjit S, Ma S, Cruz MI, Benitez C, Rozeboom AM, Ceuleers H, Berry DL, Jacobsen BM, Raj GV, Riggins RB. Olukoya AO, et al. Among authors: stires h. J Endocr Soc. 2023 Sep 15;7(10):bvad117. doi: 10.1210/jendso/bvad117. eCollection 2023 Aug 28. J Endocr Soc. 2023. PMID: 37766843 Free PMC article.
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.
Bahnassy S, Stires H, Jin L, Tam S, Mobin D, Balachandran M, Podar M, McCoy MD, Beckman RA, Riggins RB. Bahnassy S, et al. Among authors: stires h. bioRxiv [Preprint]. 2023 Aug 22:2023.08.21.554116. doi: 10.1101/2023.08.21.554116. bioRxiv. 2023. Update in: Endocrinology. 2023 Nov 2;164(12):bqad159. doi: 10.1210/endocr/bqad159 PMID: 37662291 Free PMC article. Updated. Preprint.
Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality.
Unger JM, Stires H, Levit LA, Stewart M, McKelvey BA, Canin B, Dressler E, Flaherty K, Fredette P, Jones L, McCann P, Miller T, Onitilo AA, Palmieri F, Patel T, Paul R, Smith GL, Bruinooge SS, Garrett-Mayer E, Lei XJ, Alva A, Schenkel C. Unger JM, et al. Among authors: stires h. JCO Oncol Pract. 2023 Oct;19(10):907-916. doi: 10.1200/OP.23.00185. Epub 2023 Aug 29. JCO Oncol Pract. 2023. PMID: 37643386 Free PMC article.
A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets.
McKelvey BA, Berk A, Chin L, Hudgens S, Kudel I, O'Hagan RC, Patel A, Scott J, Stires H, Wang S, Wujcik D, Stewart M, Allen J. McKelvey BA, et al. Among authors: stires h. JCO Clin Cancer Inform. 2023 Feb;7:e2200161. doi: 10.1200/CCI.22.00161. JCO Clin Cancer Inform. 2023. PMID: 36821804
ROS is a master regulator of in vitro matriptase activation.
Gaymon DO, Barndt R, Stires H, Riggins RB, Johnson MD. Gaymon DO, et al. Among authors: stires h. PLoS One. 2023 Jan 30;18(1):e0267492. doi: 10.1371/journal.pone.0267492. eCollection 2023. PLoS One. 2023. PMID: 36716335 Free PMC article.
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
Stewart MD, Merino Vega D, Arend RC, Baden JF, Barbash O, Beaubier N, Collins G, French T, Ghahramani N, Hinson P, Jelinic P, Marton MJ, McGregor K, Parsons J, Ramamurthy L, Sausen M, Sokol ES, Stenzinger A, Stires H, Timms KM, Turco D, Wang I, Williams JA, Wong-Ho E, Allen J. Stewart MD, et al. Among authors: stires h. Oncologist. 2022 Mar 11;27(3):167-174. doi: 10.1093/oncolo/oyab053. Oncologist. 2022. PMID: 35274707 Free PMC article.
16 results